Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Drug companies' evidence to justify advertising
Author: Wade, V.
Mansfield, P.
McDonald, P.
Citation: The Lancet, 1989; 334(8674):1261-1264
Publisher: Elsevier
Issue Date: 1989
ISSN: 0140-6736
Statement of
V.A. Wade, P.R. Mansfield, P.J. Mcdonald
Abstract: Ten international pharmaceutical companies were asked by letter to supply their best evidence in support of marketing claims for seventeen products. Fifteen replies were received. Seven replies cited a total of 67 references: 31 contained relevant original data and only 13 were controlled trials, all of which had serious methodological flaws. There were four reports of changes in advertising claims and one company ceased marketing nikethamide in the third world. Standards of evidence used to justify advertising claims are inadequate.
Keywords: Product Surveillance, Postmarketing; Fraud; Developing Countries; Drug Industry; Health Promotion; Advertising as Topic; Evaluation Studies as Topic
Description: Originally published as Volume 2, Issue 8674
Rights: © 1989 Published by Elsevier Ltd.
RMID: 0030011337
DOI: 10.1016/S0140-6736(89)91862-X
Appears in Collections:Public Health publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.